Roble Belko & Company’s Cognex CGNX Stock Holding History

Roble Belko & Company’s Portfolio CGNX Stock Details CGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-236	Closed	-$18K	–	326
2022 Q1	$18K	Buy	+236	New	+$16.2K	﹤0.01%	250

Other funds holding CGNX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Roble Belko & Company's CGNX Position: Q2 2022 in Review

Roble Belko & Company sold out of Cognex (CGNX) in Q2 2022, closing a stake of 236 shares — an estimated $18K sold.

Roble Belko & Company first reported a position in CGNX in Q1 2022 and held it in 1 quarter. The position peaked at $18K in Q1 2022. 490 funds tracked by Wall St. Rank hold CGNX as of Q2 2022.

Roble Belko & Company reported no remaining Cognex position as of Q2 2022 after selling out during the quarter.
Roble Belko & Company sold 236 Cognex shares in Q2 2022, an estimated $18K.
Roble Belko & Company first reported a position in Cognex in Q1 2022 and held it in 1 quarter.
Roble Belko & Company's Cognex position peaked at $18K in Q1 2022.
490 funds tracked by Wall St. Rank held Cognex as of Q2 2022.

Based on Roble Belko & Company's 13F filing for Q2 2022, filed 10 Aug 2022.